US drugmakers have begun reaching out to explore contract manufacturing possibilities to Piramal Pharma Ltd. as they gear up ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Isha Ambani Piramal stepped into the spotlight at the Business of Fashion (BOF) Gala in Paris, dressed in a breathtaking ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma’s stock price rose 2% in the opening trading on September 30 after the business received an Establishment ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) ...

Nandini Piramal has earned an MBA from Stanford University Graduate School of Business, California. She also holds a Bachelor ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...